Papillomavirus-Associated Tumor Formation Critically Depends on c-Fos Expression Induced by Viral Protein E2 and Bromodomain Protein Brd4

• Maria Delcuratolo ,

  Contributed equally to this work with: Maria Delcuratolo, Jasmin Fertey

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Jasmin Fertey ,

  Contributed equally to this work with: Maria Delcuratolo, Jasmin Fertey

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Markus Schneider,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Johanna Schuetz,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Natalie Leiprecht,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Benjamin Hudjetz,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Stephan Brodbeck,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Silke Corall,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Marcel Dreer,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Roxana Michaela Schwab,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Martin Grimm,

  Affiliation Department of Oral and Maxillofacial Surgery, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Shwu-Yuan Wu,

  Affiliation University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, Department of Biochemistry, Department of Pharmacology, Dallas, Texas, United States of America

  ⨯
• Frank Stubenrauch,

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Cheng-Ming Chiang,

  Affiliation University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, Department of Biochemistry, Department of Pharmacology, Dallas, Texas, United States of America

  ⨯
• Thomas Iftner

  * E-mail: thomas.iftner@med.uni-tuebingen.de

  Affiliation Division of Experimental Virology, Institute of Medical Virology, University Hospital Tübingen, Tübingen, Germany

  ⨯